Dermatology

Supportive Care

Questions discussed in this category

Will you offer patients urea-based creams or topical diclofenac for hand-foot prophylaxis with capecitabine after the D-TORCH trial results?

D-TORCH compared topical diclofenac to placebo.

4 Answers available

How do you manage patients with chemotherapy-induced paronychia?

1 Answer available

How do you manage docetaxel or other taxane-induced nail toxicity?

e.g., subungual hemorrhage and onycholysis?

1 Answer available

Papers discussed in this category

Cancer,

Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.

Eur J Oncol Nurs, 2011 Jul 23

Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.

Support Care Cancer, 2013 Dec 22

Cryotherapy for docetaxel-induced hand and nail toxicity: randomised control trial.

Breast Cancer Res. Treat., 2017 May 09

A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant/adjuvant docetaxel chemotherapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024 Feb 27

Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.

Related Topics in Dermatology